Binggang Xiang1, Guoying Zhang1, Shaojing Ye1, Rui Zhang1, Cai Huang1, Jun Liu1, Min Tao1, Changgeng Ruan1, Susan S Smyth1, Sidney W Whiteheart1, Zhenyu Li1. 1. From Division of Cardiovascular Medicine, Saha Cardiovascular Research Center (B.X., G.Z., S.Y., R.Z., S.S.S., Z.L.), Department of Molecular and Cellular Biochemistry (S.Y., S.W.W.), and Markey Cancer Center (C.H.), University of Kentucky, Lexington; Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale (J.L.); Department of Oncology (M.T.) and Jiangsu Institute of Hematology, Department of Hematology (C.R.), First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; and Lexington Veterans Affairs Medical Center, Lexington, KY (S.S.S.).
Abstract
BACKGROUND: Integrins are heterodimeric (α/β) membrane proteins that play fundamental roles in many biological processes, for example, cell adhesion and spreading, which are important for platelet function and hemostasis. The molecular mechanism that regulates integrin activation is not completely understood. METHODS AND RESULTS: Here, we show that VPS33B, a member of the Sec1/Munc18 family, binds directly to the integrin β subunit. Overexpression of VPS33B in Chinese hamster ovary cells potentiated αIIbβ3 outside-in signaling but not inside-out signaling. Platelets, from megakaryocyte- and platelet-specific VPS33B conditional knockout mice, had normal morphology, yet their spreading on fibrinogen was impaired and they failed to support clot retraction. Platelet aggregation and ATP secretion in response to low-dose agonists were reduced in the VPS33B knockout mice. αIIbβ3-mediated endocytosis of fibrinogen was also defective. Tail bleeding times and times to occlusion in an FeCl3-induced thrombosis model were prolonged in the VPS33B knockout mice. Furthermore, VPS33B acted upstream of the RhoA-ROCK-MLC and Rac1-dependent pathways that lead to clot retraction and cell spreading, respectively. CONCLUSIONS: Our work demonstrates that vesicular trafficking complexes, containing VPS33B, are a novel class of modifiers of integrin function. Our data also provide insights into the molecular mechanism and treatment of arthrogryposis, renal dysfunction, and cholestasis syndrome.
BACKGROUND: Integrins are heterodimeric (α/β) membrane proteins that play fundamental roles in many biological processes, for example, cell adhesion and spreading, which are important for platelet function and hemostasis. The molecular mechanism that regulates integrin activation is not completely understood. METHODS AND RESULTS: Here, we show that VPS33B, a member of the Sec1/Munc18 family, binds directly to the integrin β subunit. Overexpression of VPS33B in Chinese hamster ovary cells potentiated αIIbβ3 outside-in signaling but not inside-out signaling. Platelets, from megakaryocyte- and platelet-specific VPS33B conditional knockout mice, had normal morphology, yet their spreading on fibrinogen was impaired and they failed to support clot retraction. Platelet aggregation and ATP secretion in response to low-dose agonists were reduced in the VPS33B knockout mice. αIIbβ3-mediated endocytosis of fibrinogen was also defective. Tail bleeding times and times to occlusion in an FeCl3-induced thrombosis model were prolonged in the VPS33B knockout mice. Furthermore, VPS33B acted upstream of the RhoA-ROCK-MLC and Rac1-dependent pathways that lead to clot retraction and cell spreading, respectively. CONCLUSIONS: Our work demonstrates that vesicular trafficking complexes, containing VPS33B, are a novel class of modifiers of integrin function. Our data also provide insights into the molecular mechanism and treatment of arthrogryposis, renal dysfunction, and cholestasis syndrome.
Authors: Seiji Tadokoro; Sanford J Shattil; Koji Eto; Vera Tai; Robert C Liddington; Jose M de Pereda; Mark H Ginsberg; David A Calderwood Journal: Science Date: 2003-10-03 Impact factor: 47.728
Authors: Markus Moser; Martina Bauer; Stephan Schmid; Raphael Ruppert; Sarah Schmidt; Michael Sixt; Hao-Ven Wang; Markus Sperandio; Reinhard Fässler Journal: Nat Med Date: 2009-02-22 Impact factor: 53.440
Authors: Nikolay L Malinin; Li Zhang; Jeongsuk Choi; Alieta Ciocea; Olga Razorenova; Yan-Qing Ma; Eugene A Podrez; Michael Tosi; Donald P Lennon; Arnold I Caplan; Susan B Shurin; Edward F Plow; Tatiana V Byzova Journal: Nat Med Date: 2009-02-22 Impact factor: 53.440
Authors: Hong Yang; Sean Lang; Zhimin Zhai; Ling Li; Walter H A Kahr; Pingguo Chen; Jelena Brkić; Christopher M Spring; Matthew J Flick; Jay L Degen; John Freedman; Heyu Ni Journal: Blood Date: 2009-03-30 Impact factor: 22.113
Authors: Achim Obergfell; Koji Eto; Attila Mocsai; Charito Buensuceso; Sheri L Moores; Joan S Brugge; Clifford A Lowell; Sanford J Shattil Journal: J Cell Biol Date: 2002-04-08 Impact factor: 10.539
Authors: Robert Gruber; Clare Rogerson; Christian Windpassinger; Blerida Banushi; Anna Straatman-Iwanowska; Joanna Hanley; Federico Forneris; Robert Strohal; Peter Ulz; Debra Crumrine; Gopinathan K Menon; Stefan Blunder; Matthias Schmuth; Thomas Müller; Holly Smith; Kevin Mills; Peter Kroisel; Andreas R Janecke; Paul Gissen Journal: J Invest Dermatol Date: 2016-12-23 Impact factor: 8.551
Authors: C T H Jonker; R Galmes; T Veenendaal; C Ten Brink; R E N van der Welle; N Liv; J de Rooij; A A Peden; P van der Sluijs; C Margadant; J Klumperman Journal: Nat Commun Date: 2018-02-23 Impact factor: 14.919